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Intra-articular injection of bone marrow derived mesenchymal stem cells (MSCs) has therapeutic potential for Rheumatoid Arthritis (RA). Secreted trophic factors reduce tissue injury, prevent degradation and promote repair via paracrine signaling. The aim of this study is to evaluate MSC serum-free conditioned medium (SF-CM) as a therapy for antigen-induced arthritis (AIA).  

15µl of concentrated SF-CM of murine MSCs was injected intra-articularly 1 day following induction of arthritis, with injection of SF-medium without pre-conditioning applied as controls. Measurements for knee joint diameter represented swelling whilst disease severity was assessed using an arthritis index (AI) calculated from histological scores for synovial infiltrate, hyperplasia, synovial exudate and cartilage depletion.  Serum concentration of pro-inflammatory cytokine TNFα was also measured. 

In SF-CM treated mice, disease severity was significantly less than in control-treated at 3 and 7 days post-arthritis induction (p<0.001, student’s t-test). At day 3, synovial infiltrate, hyperplasia and cartilage depletion were significantly reduced from control-treated scores (p<0.05, student’s t-test). Recovery from peak swelling significantly improved from control-treated animals at days 2, 3, 7 and 14 (p<0.05, 2-way ANOVA). Serum concentration of circulating TNFα was also significantly decreased (pVal, test type).

We demonstrate therapeutic potential of SF-CM delivered intra-articularly in a pre-clinical RA model, showing ameliorated disease severity, reduced synovial infiltrate, hyperplasia and cartilage depletion and enhanced swelling recovery. Further work is required to identify the mechanisms involved. 
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